Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Added a government funding notice and operating-status guidance, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%
- Check20 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedBump from v3.0.1 to v3.0.2 and removal of the Back to Top link; no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while key terms related to pembrolizumab and various pharmacological classifications have been removed.SummaryDifference0.9%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.